日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

多发性骨髓瘤中EZH2的过度表达与预后不良和细胞周期调控失调相关。

Pawlyn, C; Bright, M D; Buros, A F; Stein, C K; Walters, Z; Aronson, L I; Mirabella, F; Jones, J R; Kaiser, M F; Walker, B A; Jackson, G H; Clarke, P A; Bergsagel, P L; Workman, P; Chesi, M; Morgan, G J; Davies, F E

Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma

手术递送药物释放型聚乳酸-羟基乙酸共聚物/聚乙二醇糊剂,对胶质母细胞瘤具有体内疗效

Smith, S J; Rahman, C V; Clarke, P A; Ritchie, A A; Gould, T W; Ward, J H; Shakesheff, K M; Grundy, R G; Rahman, R

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance

个性化癌症治疗:分子诊断、预测性生物标志物和耐药性

Gonzalez de Castro, D; Clarke, P A; Al-Lazikani, B; Workman, P

Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors

I类和I/IV类双重磷脂酰肌醇3-激酶(PI3K)抑制剂的临床前发现和临床开发进展

Shuttleworth, S J; Silva, F A; Cecil, A R L; Tomassi, C D; Hill, T J; Raynaud, F I; Clarke, P A; Workman, P

De-regulation of the sonic hedgehog pathway in the InsGas mouse model of gastric carcinogenesis

在InsGas小鼠胃癌模型中,音猬因子信号通路失调

El-Zaatari, M; Tobias, A; Grabowska, A M; Kumari, R; Scotting, P J; Kaye, P; Atherton, J; Clarke, P A; Powe, D G; Watson, S A

Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells

Jurkat T细胞中三酰甘油的积累与细胞凋亡有关。

Al-Saffar, N M S; Titley, J C; Robertson, D; Clarke, P A; Jackson, L E; Leach, M O; Ronen, S M

Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.

针对人类结直肠腺癌中突变的 Ki-ras 的反义治疗

Andreyev H J, Ross P J, Cunningham D, Clarke P A

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

结直肠癌患者中 Kirsten ras 基因突变:“RASCAL II”研究

Andreyev, H J; Norman, A R; Cunningham, D; Oates, J; Dix, B R; Iacopetta, B J; Young, J; Walsh, T; Ward, R; Hawkins, N; Beranek, M; Jandik, P; Benamouzig, R; Jullian, E; Laurent-Puig, P; Olschwang, S; Muller, O; Hoffmann, I; Rabes, H M; Zietz, C; Troungos, C; Valavanis, C; Yuen, S T; Ho, J W; Croke, C T; O'Donoghue, D P; Giaretti, W; Rapallo, A; Russo, A; Bazan, V; Tanaka, M; Omura, K; Azuma, T; Ohkusa, T; Fujimori, T; Ono, Y; Pauly, M; Faber, C; Glaesener, R; de Goeij, A F; Arends, J W; Andersen, S N; Lövig, T; Breivik, J; Gaudernack, G; Clausen, O P; De Angelis, P D; Meling, G I; Rognum, T O; Smith, R; Goh, H S; Font, A; Rosell, R; Sun, X F; Zhang, H; Benhattar, J; Losi, L; Lee, J Q; Wang, S T; Clarke, P A; Bell, S; Quirke, P; Bubb, V J; Piris, J; Cruickshank, N R; Morton, D; Fox, J C; Al-Mulla, F; Lees, N; Hall, C N; Snary, D; Wilkinson, K; Dillon, D; Costa, J; Pricolo, V E; Finkelstein, S D; Thebo, J S; Senagore, A J; Halter, S A; Wadler, S; Malik, S; Krtolica, K; Urosevic, N

Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy

胃肠道恶性肿瘤中明胶酶(MMP-2 和 -9)的表达

Parsons, S L; Watson, S A; Collins, H M; Griffin, N R; Clarke, P A; Steele, R J

Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI

腺病毒2型病毒相关RNA与蛋白激酶DAI结合所需的结构特征

Clarke, P A; Pe'ery, T; Ma, Y; Mathews, M B